Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma
3 clinical trials · Condition
◉ Watch Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma
| Record | Firm | Date |
|---|---|---|
| Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma (NCT01829568) | National Cancer Institute (NCI) | 2013-06-26 |
| Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas (NCT01193842) | National Cancer Institute (NCI) | 2010-10-06 |
| Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma (NCT01145495) | National Cancer Institute (NCI) | 2010-06-15 |
Track Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.